Dataset from Parallel Group Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus Treated With Oral Antidiabetic(s)

The objectives of this clinical trial are to compare the effects of exenatide once weekly and insulin glargine on blood glucose control, body weight, lipids, safety, and tolerability.

本临床试验的目的为比较艾塞那肽周制剂（exenatide once weekly）与甘精胰岛素（insulin glargine）在血糖控制、体重、血脂及安全性与耐受性方面的效果。